Ugen, Kenneth E.
University of California, San Francisco · University of South Florida · Moffitt Cancer Center
3 papers on CoChatORCID 0000-0002-7797-2049
Most cited papers
- Verified
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma
Daud, A. I., DeConti, R. C., Andrews, S., Urbas, P., Riker, A. I., Sondak, V. K., Munster, P. N., Sullivan, D. M., Ugen, K. E., Messina, J. L., et al. (2008) · Journal of Clinical Oncology
Microbial Inactivation MethodsImmunotherapy and Immune Responses
Cited by 701
- Verified
Intracranially Administered Anti-Αβ Antibodies Reduce β-Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation
Wilcock, D. M., DiCarlo, G., Henderson, D., Jackson, J., Clarke, K., Ugen, K. E., Gordon, M. N., & Morgan, D. (2003) · The Journal of Neuroscience
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 232
- Verified
Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration
Wilcock, D. M., Munireddy, S. K., Rosenthal, A., Ugen, K. E., Gordon, M. N., & Morgan, D. (2004) · Neurobiology of Disease
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 202
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free